Atracurium Besylate Injection, Solution
Product Images NDC 71288-702

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atracurium Besylate (NDC 71288-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atr09 0002 01

FDA Label Image

Atr09 0002 02

FDA Label Image

Atr09 0002 03

This text is a collection of warnings, instructions and information about Atracurium, a medication used to cause muscle relaxation during surgery or other medical procedures requiring intubation. Atracurium is a paralyzing agent and can cause respiratory arrest, making it necessary for assisted respiration facilities to be immediately available. The information includes details on dosage and storage, and advises to discard unused portions after 14 days. The text also includes warnings about health hazards and advice for safe usage of the medication.*

FDA Label Image

Atr09 0002 04

FDA Label Image

Atr09 0002 05

This is a description for a drug called Atracurium Besylate Injection, USP. It contains warnings about respiratory arrest and advises that artificial respiration be made immediately available in a facility. The drug comes in 10x10mL packages that must be refrigerated between 2°C and 8°C. It is written in a mix of uppercase and lowercase letters and includes some non-English characters.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.